Summary An assessment has been made of the reproducibility of measuring tumour proliferation using in vivo iododeoxyuridine (IUdR) dissolved in 10 ml of sterile water. This was performed with informed consent and Hospital Ethical Committee approval. The tumours were then either biopsied (n = 28) or resected (n = 25) after a mean interval of 6.2 h (range 3.0-14.7 h) following injection. This interval (t) was measured from the time of IUdR administration as a bolus over approximately 30s until the cessation of the sample's blood supply. The samples were then immediately fixed in 70% ethanol and stored at 4°C. Parallel samples taken from adjacent tissue were fixed in formol saline for pathological assessment. No patient had received radio-or chemotherapy prior to IUdR labelling and tumour sampling.
The in vivo incorporation of either of the thymidine analogues iododeoxyuridine (IUdR) and bromodeoxyuridine (BUdR) into human tumours in conjunction with flow cytometry (Begg et al., 1985) allows rapid estimation of the tumour labelling index (LI), the duration of S phase (Ts) and hence the potential doubling time (Tpo,) . It is hoped this will be a technique to reliably measure the proliferative rate of clonogens in an individual's tumour and will provide information that could be of clinical use as an independent indicator of prognosis. It is of particular interest in the surgical management of colorectal cancer as it may be helpful in the selection of patients for adjuvant treatment. It has already been suggested that tumours with a short Tpo, may require an accelerated regime of radiotherapy (Dische & Saunders, 1989; Begg et al., 1990) .
If this technique is to be of use clinically as a predictive test, it is important to show that the variability with measurements of Tpo, are smaller than the overall spread of values. Large assay variability will reduce the predictive accuracy. In addition, it is useful to assess the reproducibility of measurements between different institutions and that of different observers analysing the same stored data. The precision of DNA flow cytometry has been assessed with regard to DNA index (Dl) and hyperdiploid fraction (HDF) between six different institutions (Wheeless et al., 1991 dissolved in 10 ml of sterile water. This was performed with informed consent and Hospital Ethical Committee approval. The tumours were then either biopsied (n = 28) or resected (n = 25) after a mean interval of 6.2 h (range 3.0-14.7 h) following injection. This interval (t) was measured from the time of IUdR administration as a bolus over approximately 30s until the cessation of the sample's blood supply. The samples were then immediately fixed in 70% ethanol and stored at 4°C. Parallel samples taken from adjacent tissue were fixed in formol saline for pathological assessment. No patient had received radio-or chemotherapy prior to IUdR labelling and tumour sampling.
On the day of analysis, samples were digested to produce a nuclear suspension and stained for IUdR and total DNA content as previously described (Wilson et al., 1985) . In summary, the specimens were minced, then digested using 0.4 mg ml' pepsin in 0.1 M HCl and the DNA partially denatured using 2 M HCI for 15 min to expose IUdRincorporated DNA. Approximately 2 x 106 nuclei were then incubated with an anti-IUdR monoclonal antibody (BecktonDickinson) for 1 h at room temperature (1 in 20 dilution). After washing, the nuclei were incubated with a rabbit antimouse IgG FITC conjugate (Dakopatts) for a further 30 min (1 in 40 dilution). Finally, the nuclei were counterstained with propidium iodide at a concentration of 10 gmlm' (Sigma) to allow measurement of the total DNA content.
The method of data analysis has previously been described (Wilson et al., 1985) . The analyses were performed at the Gray Laboratory, Northwood on an Ortho Systems 50-H Cytofluorograph (Beckton-Dickinson) and at the Paterson Institute for Cancer Research, Manchester, using an EPICS V flow cytometer (Coulter). Both machines created light with a wavelength of 488 nm from 5 W argon ion lasers operating at 200 mW; green fluorescent light emitted by excitation of the FITC conjugate bound to the anti-IUdR monoclonal antibody was collected at 510-560 nm and red fluorescence from the excited PI above 620 nm. All data were collected from the cytometers on 1024 channels using list mode. The data analysis requires the use of software which allows regions (gates) to be set around various populations of particles. This can be used to remove debris or clumps of nuclear material from the analyses to facilitate estimations of the proportions of nuclei within each part of the cell cycle and their mean DNA content. The data were gated to exclude multiple nuclei and debris on the DNA peak vs area signals.
Data for 10,000 to 20,000 nuclei were collected from each sample. The machines were calibrated before each batch of analyses using fluorescent beads. Analysis was performed as described by Begg et al. (1985) using:
(1) TTO, = 0L8 x where 0.8 is the value assigned to A, a factor which accounts for the variation in the age structure of the cell (Steel, 1977 Figure  3 ). All of the observers used the same protocol regarding the decisions required to place the regions around the various populations of nuclei. The data analysis was always done without knowledge of which sample was being analysed and without the assistance of any other individual (Table III) .
There was a very good correlation in the ranking of the samples between two different observers; but as in the previous comparison there were highly significant differences in all of the parameters, except DI and LI at the Paterson Institute. In both the inter-institutional and inter-observer studies, LI values were better correlated than both RM and Ts, and the calculated Tp,, values reflected this. Correction factor In order to reduce the degree of variation seen, attempts were made to correct for any factor which may differ between institutions or observers. The 42 samples which had been run on all of the various observer/laboratory combinations (Table II) were compared against a standard laboratory/ observer combination which was GW at the Gray Lab. This combination was chosen as the most established and experienced one.
Three approaches were assessed on their ability to reduce the inter-institutional and -observer variation.
(i) Addition or subtraction of a factor equal to the difference between the mean for each of the laboratory/observer combinations and that of the standard combination. (ii) Division of each value by a factor equal to the ratio of the mean for each laboratory/observer combination and the mean for the standard. (iii) A linear regression line was fitted for each of the laboratory/observer combinations of the value for that combination against the corresponding value as the standard. These regression lines were used to correct each of the experimental values. Correction factors (i) and (ii) (Table IV and Figure 4 ). Tpot (days) 3.5 (0.9-9.1) 3.3 (0.9-9.0) r = 0.87 P<0.001 and therefore a logarithmic transformation was applied to these variables. The un-transformed values are also shown to allow comparison with published results from other studies. This analysis indicates that there are highly significant differences between different samples once the variation due to different observers and institutions have been taken into account. The estimates of ploidy (diploid vs aneuploid) show no significant differences between observers (P = 0.11) or institutions (P = 0.12), but highly significant differences between individual tumours (P<0.001). Once these effects are allowed for, 92% of the samples are correctly categorised into above or below the median value.
Global analysis

Discussion
Cell proliferation kinetics have been shown to be a prognostic factor for several types of cancer as reviewed by Tubiana & Courdi (1989) . These studies have been carried out using either tritiated thymidine labelling or flow cytometric measurements of S-phase fractions. The first method is time consuming and has limited clinical application due to the requirement for the administration of a radioactive isotope. The second method may over-estimate proliferative capacity as there is evidence that cells can arrest in phases other than GI (Drewinko et al., 1984) . Furthermore, it is difficult to exclude the normal stromal nuclei from the analysis. The development of a monoclonal antibody to the halogenated pyrimidines IUdR and BUdR (Gratzner, 1982) , allowed the establishment of a rapid technique for the simultaneous measurement of tumour DNA content, labelling index (LI) and an estimation of the duration of S-phase (Ts). These measurements provide the basis for the calculation of Tp,,,.
Although there are several clinical studies published using this technique on a variety of tumour types (Wilson et al., 1988; Begg et al., 1990; Rew et al., 1991; Riccardi et al., 1991; Rew et al., 1992) , the reliability and reproducibility of the method has yet to be examined in detail. It has been demonstrated that the measurement of ploidy may be performed accurately both between and within institutions (Wheeless et al., 1991) . This study confirms the finding in that there are no significant differences in ploidy determinations between the present institutions, individuals analysing the same stored data and in samples re-run on the same machine. As regards the other IUdR-related parameters (LI, RM, Ts and Tp, 0) (White & Meistrich, 1986; White, 1989; White et al., 1990 ). However, comparisons of these sophisticated approaches with the more simple RM method (Begg et al., 1985) suggest that the difference in Tpot calculated is small and identification of the appropriate regions is easier with the RM method (Wilson & McNally, 1991 The degree of machine reproducibility was tested by reanalysing nuclei from 30 specimens stored for 1 week at 4°C in the dark. There were no significant differences in the measured values obtained, illustrating both the reproducibility of the technique and the efficacy of sample storage for a short period of time. A further source of variability is the presence of heterogeneity with in individual tumours. This particular problem has been previously addressed (Begg et al., 1988; Rew et al., 1991) and forms the basis of a paper presently being produced.
The median Tp,,0 value has been previously used as a watershed to determine if a tumour is a fast or slow proliferator (Begg et al., 1990 
